04:48 PM EST, 02/26/2025 (MT Newswires) -- Sarepta Therapeutics ( SRPT ) reported Q4 non-GAAP net earnings late Wednesday of $1.90 per diluted share, up from $0.82 a year earlier.

Analysts polled by FactSet expected $2.00.

Total revenue for the quarter ended Dec. 31 was $658.4 million, up from $396.8 million a year earlier.

Analysts surveyed by FactSet expected $636.1 million.

Shares of the company were down over 3% in after-hours activity.